SCHEMBL24056281

SCHEMBL24056281

c1ccc(-c2ccc(N(c3ccc(-c4ccc5c(n4)sc4ccccc45)cc3)c3ccc(-c4cc5ccccc5c5ccccc45)cc3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.36
▸ RAB9A P51151 6/20 0.36
▸ ALDH1A1 P00352 6/20 0.36
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ CYP11B1 P15538 1/20 0.36
▸ LIMK1 P53667 2/20 0.36
▸ KDM4E B2RXH2 4/20 0.34
▸ HPGD P15428 4/20 0.34
▸ ACACA Q13085 1/20 0.33
▸ MAPT P10636 6/20 0.33
▸ MEN1 O00255 6/20 0.33
▸ KMT2A Q03164 6/20 0.33
▸ MPI P34949 1/20 0.33
▸ GPR84 Q9NQS5 2/20 0.32
▸ TLR9 Q9NR96 3/20 0.32
▸ L3MBTL1 Q9Y468 3/20 0.32
▸ ATM Q13315 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24055864 0.89 NPC1 (0.42) NPC1RAB9AALDH1A1SMN1; SMN2NFKB1
SCHEMBL24056517 0.88 ENPP1 (0.38) NPC1RAB9AALDH1A1SMN1; SMN2NFKB1
SCHEMBL24056836 0.88 CYP11B1 (0.36) ALDH1A1CYP11B1KDM4EHPGDMAPT
SCHEMBL25663224 0.87 RAB9A (0.33) NPC1RAB9AALDH1A1SMN1; SMN2NFKB1
SCHEMBL24055544 0.86 CYP1A1 (0.37) NPC1RAB9AALDH1A1SMN1; SMN2NFKB1
SCHEMBL25663222 0.86 RAB9A (0.35) NPC1RAB9AALDH1A1SMN1; SMN2NFKB1
SCHEMBL25663221 0.86 RAB9A (0.39) NPC1RAB9AALDH1A1SMN1; SMN2NFKB1
SCHEMBL25663228 0.84 ALDH1A1 (0.36) NPC1RAB9AALDH1A1SMN1; SMN2NFKB1
SCHEMBL22671295 0.83 ALDH1A1 (0.38) RAB9AALDH1A1SMN1; SMN2CYP11B1LIMK1
SCHEMBL25663220 0.83 RAB9A (0.38) NPC1RAB9AALDH1A1SMN1; SMN2NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230157159-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-05-18 — — US disclosed
US-20230157159-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-05-18 — — US disclosed
WO-2021235906-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-11-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230157159-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME NR0B1, AHR, ARL1 NPC1 2413/4885RAB9A 2249/4885ALDH1A1 628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback